Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma

Oncology Reports

Volumn 34, Issue 3, 2015, Pages 1319-1326

  Shi, Ping ^a   Fang, Changcun ^a   Pang, Xinyan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

AEG 1; Cardiac myxoma; CCR5; Epithelial to mesenchymal transition

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GELATINASE A; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PEPTIDES AND PROTEINS; PROTEIN AEG 1; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIMENTIN; CCL3 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN; CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HEART ATRIUM MYXOMA; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; TUMOR VOLUME; AGED; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEART ATRIUM; HEART TUMOR; MIDDLE AGED; MYXOMA; PATHOLOGY; TUMOR CELL LINE;

AGED; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHEMOKINE CCL3; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEART ATRIA; HEART NEOPLASMS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MYXOMA; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CCR5; SIGNAL TRANSDUCTION;

EID: 84937201772     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4081     Document Type: Article

References (28)

1. Lee HS, Kim HK, Park EA, Kim KH, Kim YJ and Sohn DW: Left atrial intramural hematoma after removal of atrial myxoma: Cardiac magnetic resonance in the differential diagnosis of intracardiac mass. J Cardiovasc Ultrasound 22: 205-208, 2014.
2. Watanabe H, Nara I, Yamaura G, Iino K, Iino T, Shimbo M, Seki K and Ito H: Blood balloon induced by an atrial myxoma in the heart. Circulation 130: 2351-2353, 2014.
3. Anpalakhan S, Ramasamy D and Fan KS: An unusual presentation of atrial myxoma. Singapore Med J 55: e156-e158, 2014.
4. Choi K, Jung D, Hong SW, Jeon Y and Kim SO: Extra cardiac tumor misdiagnosed as a left atrial myxoma. Korean J Anesthesiol 67 (Suppl): S67-S68, 2014.
5. Di Vito A, Mignogna C and Donato G: The mysterious pathways of cardiac myxomas: A review of histogenesis, pathogenesis and pathology. Histopathology 66: 321-332, 2015.
6. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ and Fisher PB: Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592-3602, 2002.
7. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet JM, et al: Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119: 465-477, 2009.
8. Lee SG, Jeon HY, Su ZZ, Richards JE, Vozhilla N, Sarkar D, Van Maerken T and Fisher PB: Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 28: 2476-2484, 2009.
9. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poorprognosis breast cancer. Cancer Cell 15: 9-20, 2009.
10. Liu K, Guo L, Miao L, Bao W, Yang J, Li X, Xi T and Zhao W: Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer Drugs 24: 494-503, 2013.
11. Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, et al: Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319-3326, 2008.
12. Weber CE, Li NY, Wai PY and Kuo PC: Epithelial-mesenchymal transition, TGF-β, and osteopontin in wound healing and tissue remodeling after injury. J Burn Care Res 33: 311-318, 2012.
13. Soria G and Ben-Baruch A: The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267: 271-285, 2008.
14. Mencarelli A, Graziosi L, Renga B, Cipriani S, D'Amore C, Francisci D, Bruno A, Baldelli F, Donini A and Fiorucci S: CCR5 antagonism by maraviroc reduces the potential for gastric cancer cell dissemination. Transl Oncol 6: 784-793, 2013.
15. Sasaki S, Baba T, Shinagawa K, Matsushima K and Mukaida N: Crucial involvement of the CCL3-CCR5 axis-mediated fibroblast accumulation in colitis-associated carcinogenesis in mice. Int J Cancer 135: 1297-1306, 2014.
16. Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H, Oyama Y, Sawada Y, Tamura J, Nagai R, et al: Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J 68: 488-493, 2004.
17. He W, He S, Wang Z, Shen H, Fang W, Zhang Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated gene-1 (AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling. BMC Cancer 15: 107, 2015.
18. Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y, Hao M, Sheng S, Sun Y, Zhang H, et al: Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway. Int J Biol Macromol 64: 106-110, 2014.
19. Khorramdelazad H, Mortazavi Y, Momeni M, Arababadi MK, Khandany BK, Moogooei M and Hassanshahi G: Lack of correlation between the CCR5-Δ32 mutation and acute myeloid leukemia in Iranian patients. Indian J Hematol Blood Transfus 31: 29-31, 2015.
20. Shi Y, Wu H, Zhang M, Ding L, Meng F and Fan X: Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol 8: 89, 2013.
21. Shih JY and Yang PC: The EMT regulator slug and lung carcinogenesis. Carcinogenesis 32: 1299-1304, 2011.
22. Chowdhury I, Thompson WE and Thomas K: Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway. J Cell Physiol 229: 998-1004, 2014.
23. Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer therapy. Pharmacol Ther 141: 160-171, 2014.
24. Wang F, Ke ZF, Wang R, Wang YF, Huang LL and Wang LT: Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway. Biochem Biophys Res Commun 452: 933-939, 2014.
25. Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z and Zhou J: CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Lett 358: 124-135, 2015.
26. Bhat FA, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S, Raja Singh P, Srinivasan N and Arunakaran J: Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem 25: 1132-1139, 2014.
27. Yao C, Lv S, Han M, Zhang J, Zhang Y, Zhang L, Yi R, Zhuang D and Wu J: The association of Crk-like adapter protein with poor prognosis in glioma patients. Tumour Biol 35: 5695-5700, 2014.
28. Srivastava J, Robertson CL, Rajasekaran D, Gredler R, Siddiq A, Emdad L, Mukhopadhyay ND, Ghosh S, Hylemon PB, Gil G, et al: AEG-1 regulates retinoid X receptor and inhibits retinoid signaling. Cancer Res 74: 4364-4377, 2014.